BioRem Inc. (CVE:BRM – Get Free Report) Director Derek Webb sold 120,000 shares of the firm’s stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of C$2.93, for a total value of C$351,600.00.
BioRem Trading Up 1.4 %
Shares of BRM stock traded up C$0.04 during trading hours on Tuesday, hitting C$2.97. 99,908 shares of the company were exchanged, compared to its average volume of 30,846. The company has a debt-to-equity ratio of 48.97, a quick ratio of 1.08 and a current ratio of 1.57. BioRem Inc. has a fifty-two week low of C$0.88 and a fifty-two week high of C$3.39. The company has a 50 day simple moving average of C$2.67 and a two-hundred day simple moving average of C$2.32. The firm has a market cap of C$46.63 million, a P/E ratio of 13.95 and a beta of 0.85.
About BioRem
Featured Articles
- Five stocks we like better than BioRem
- Are Penny Stocks a Good Fit for Your Portfolio?
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- Ride Out The Recession With These Dividend Kings
- Netflix Is On Track To Hit $1,000 By Christmas
- Russell 2000 Index, How Investors Use it For Profitable Trading
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Receive News & Ratings for BioRem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRem and related companies with MarketBeat.com's FREE daily email newsletter.